SMALL BUSINESS TECHNOLOGY TRANSFER PROGRAM NIH GUIDE, Volume 22, Number 32, September 3, 1993 P.T. 34 Keywords: Technology Transfer National Institutes of Health Application Receipt Date: December 1, 1993 The purpose of this announcement is to inform the public of a new set- aside funding opportunity that requires collaboration of small businesses with research institutions. Public Law 102-564, signed October 28, 1992, requires the National Institutes of Health (NIH), Public Health Service, Department of Health and Human Services, and certain other Federal agencies to reserve a specified amount of their extramural research or research and development (R&D) budgets for a Small Business Technology Transfer (STTR) program. The legislation is intended to: o stimulate and foster scientific, technical, and technological innovation through cooperative R&D carried out between small businesses and research institutions; o foster technology transfer between small businesses and research institutions; o increase private sector commercialization of innovations derived from Federal R&D; and o foster and encourage participation of socially and economically disadvantaged small businesses and women-owned small businesses in technological innovation. The STTR program is a three-year pilot program the begins in fiscal year (FY) 1994 and consists of the following three phases: PHASE I: The objective of this phase is to determine the scientific, technical, and commercial merit and feasibility of the proposed cooperative effort and the quality of performance of the small business concern, prior to providing further Federal support in Phase II. PHASE II: The objective of this phase is to continue the research or R&D efforts initiated in Phase I. Funding shall be based on the results of Phase I and the scientific and technical merit and commercial potential of the Phase II application. PHASE III: The objective of this phase, where appropriate, is for the small business concern to pursue with non-federal funds the commercialization of the results of the research or R&D funded in Phases I and II. The amount and period of support for STTR awards are as follows: PHASE I: Awards may not exceed $100,000 for direct costs, indirect costs, and negotiated fixed fee for a period normally not to exceed one year. PHASE II: Awards may not exceed $500,000 for direct costs, indirect costs, and negotiated fixed fee for a period normally not to exceed two years. A Phase I award must have been issued in order to apply for a Phase II award. (ONLY Phase I awards will be issued in FY 1994.) It is anticipated that approximately 40 STTR grants will be awarded by the NIH in FY 1994 from funds set aside for this purpose. The applicant organization must be the small business. As required by the legislation, at least 40 percent of the project is to be performed by the small business and at least 30 percent of the project is to be performed by the research institution. INQUIRIES Eligibility requirements, definitions, application procedures, review considerations, application forms and instructions, and other pertinent information are contained in the "Omnibus Solicitation of the National Institutes of Health for Small Business Technology Transfer (STTR) Grant Applications," available from: Massachusetts Technological Laboratory, Inc. 13687 Baltimore Avenue Laurel, MD 20707 Telephone: (301) 206-9385 FAX: (301) 206-9722 The OMNIBUS SOLICITATION is for the single application receipt date of December 1, 1993, for grant awards to be made in FY 1994. Contact points for inquiries regarding each NIH awarding component's program interests concerning the STTR program are contained in the OMNIBUS SOLICITATION. .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||